Hepatocellular carcinoma: A multidisciplinary approach;Le carcinome hépatocellulaire: Une approche multidisciplinaire

Revue Medicale Suisse

Volumn 1, Issue 24, 2005, Pages 1621-1629

  Tempia Caliera, Adrien A ^a   Ksontini, Riadh ^a   Moradpour, Darius ^a   Denys, Alban ^a   Halkic, Nermin ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL DECISION MAKING; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; RADIODIAGNOSIS; REVIEW; TREATMENT INDICATION; ALGORITHM; LIVER TUMOR; PALLIATIVE THERAPY; PROGNOSIS;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS;

EID: 25144439622     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Bosch FX, Ribes J, Diaz M, Clerics R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004;127:S5-S16.
2. Moradpour D, Slum HE. Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005; 17:477-83.
3. Bruix J, Sherman M, Llovet JM, et al. EASL Panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-30.
4. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-17.
5. Baron RI, Brancatelli G. Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S133-43.
6. Taouli B, Losada M, Holland A, Krinski G. Resonance magneting imaging of hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S144-52.
7. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment Study of 850 patients. Cancer 1985;56:918-28.
8. Ikai I, Yamaoka Y, Yamamoto Y, et al. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: Proposal as a standard therapy. Ann Surg 1998;227:433-9.
9. Farinati F, Rinaldi M, Gianni S, Naccarato R. How should patients with hepatocellular carcinoma be staged ? Validation of a new prognostic system. Cancer 2000; 89:2266-73.
10. Llovet JM, Fuster J, Bruix J; Barcelona-Clinic Liver Cancer Group. The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004;10(2 Suppl 1):S115-20.
11. Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C.A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999;31:133-41.
12. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
13. Wakabayashi H, Ushiyama T, Ishimura K, et al. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. J Surg Oncol 2003;82:98-103.
14. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790-9.
15. Belghiti J, Regimbeau JM, Durand F, et al. Resection of hepatocellular carcinoma: An European experience on 328 cases. Hepatogastroenterology 2002; 49:41-6.
16. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004;127(5 Suppl 1):S159-66.
17. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:1201-9.
18. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37:429-42.
19. Lee JS and Thorgeirsson SS. Genome-scale profiling of gene expression in hepatocellular carcinoma: Classification, survival prediction, and identification of therapeutic targets. Gastroenterology 2004;127:S51-S55.
20. Burroughs A, Hochhauser D, Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: Two ends of the therapeutic spectrum. Lancet Oncol 2004;5:409-18.